Intuitive Surgical, Inc. (ISRG)
448.74
+4.56
(+1.03%)
USD |
NASDAQ |
Oct 29, 16:00
450.64
+1.90
(+0.42%)
After-Hours: 20:00
Intuitive Surgical Enterprise Value : 150.01B for Oct. 28, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 28, 2026 | 150.01B |
| October 27, 2026 | 150.60B |
| October 26, 2026 | 152.59B |
| October 23, 2026 | 152.82B |
| October 22, 2026 | 149.90B |
| October 21, 2026 | 144.45B |
| October 20, 2026 | 147.87B |
| October 19, 2026 | 146.20B |
| October 16, 2026 | 143.95B |
| October 15, 2026 | 144.36B |
| October 14, 2026 | 141.71B |
| October 13, 2026 | 142.35B |
| October 12, 2026 | 144.28B |
| October 09, 2026 | 143.00B |
| October 08, 2026 | 140.04B |
| October 07, 2026 | 139.73B |
| October 06, 2026 | 136.35B |
| October 05, 2026 | 136.95B |
| October 02, 2026 | 131.91B |
| October 01, 2026 | 135.13B |
| September 30, 2026 | 137.00B |
| September 29, 2026 | 140.75B |
| September 28, 2026 | 141.68B |
| September 25, 2026 | 138.28B |
| September 24, 2026 | 136.27B |
| Date | Value |
|---|---|
| September 23, 2026 | 135.84B |
| September 22, 2026 | 137.18B |
| September 21, 2026 | 137.03B |
| September 18, 2026 | 134.08B |
| September 17, 2026 | 130.62B |
| September 16, 2026 | 130.18B |
| September 15, 2026 | 128.36B |
| September 14, 2026 | 128.64B |
| September 11, 2026 | 125.52B |
| September 10, 2026 | 122.45B |
| September 09, 2026 | 119.89B |
| September 08, 2026 | 118.80B |
| September 04, 2026 | 124.66B |
| September 03, 2026 | 125.77B |
| September 02, 2026 | 126.49B |
| September 01, 2026 | 125.56B |
| August 31, 2026 | 128.25B |
| August 28, 2026 | 126.75B |
| August 27, 2026 | 124.79B |
| August 26, 2026 | 125.97B |
| August 25, 2026 | 126.48B |
| August 24, 2026 | 127.09B |
| August 21, 2026 | 128.94B |
| August 20, 2026 | 127.41B |
| August 19, 2026 | 135.64B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Stryker Corp. | 128.58B |
| Zimmer Biomet Holdings, Inc. | 25.45B |
| Abbott Laboratories | 205.26B |
| Globus Medical, Inc. | 10.43B |
| Edwards Lifesciences Corp. | 49.48B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 524.40M |
| Revenue (Quarterly) | 3.049B |
| Total Expenses (Quarterly) | 2.526B |
| EPS Diluted (Quarterly) | 1.487 |
| Gross Profit Margin (Quarterly) | 68.35% |
| Profit Margin (Quarterly) | 17.20% |
| Earnings Yield | 1.84% |
| Operating Earnings Yield | 2.33% |
| Normalized Earnings Yield | 2.030 |